Risultati per: La FDA approva il sistema di riabilitazione dell’ictus

The US Food and Drug Administration (FDA) recently approved liraglutide to treat type 2 diabetes in combination with diet and exercise, which makes it the first generic version of Victoza and the second glucagon-like peptide-1 (GLP-1) receptor agonist authorized as a generic drug.

New England Journal of Medicine, Ahead of Print.

‘Stato gold’ nell’ambito del programma ‘Eso-Angels Awards

Grocery items marketed as “healthy” will soon need to meet a new US Food and Drug Administration (FDA) rule that now focuses on whole foods.

The US Food and Drug Administration (FDA) recently approved tirzepatide, marketed as Zepbound, for moderate to severe obstructive sleep apnea (OSA) in adults with obesity, making it the first sleep apnea drug, according to an agency press release.

This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.

Cirio e Riboldi: ‘Altro fondamentale passo avanti’

This JAMA Viewpoint investigates the rising popularity of nicotine pouches, especially among youths, and how the US Food and Drug Administration must act quickly to regulate these products and curb market growth.

Si è riunito il 29 gennaio per la prima seduta del 2025

Isa-Aii, con Stroke Action Plan for Italy obiettivo 90% nel 2030

This Viewpoint discusses California’s new law that will further strengthen tobacco control and whether the FDA and other states will follow California’s example.

Esperta, la progressiva perdita dei sensi può influire negativamente sul cervello

New England Journal of Medicine, Ahead of Print.

Sospesi avvisi, rapporti, aggiornamenti dei siti e post sui social

The US Food and Drug Administration (FDA) is considering removal of oral phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter (OTC) cold medications—including DayQuil, Theraflu, and Sudafed—after an extensive review of available data determined a lack of efficacy.